Caribbean Cancer Care Services, LLC

Caribbean Cancer Care Services, LLC was paid $6.48M by Medicaid between Jan 2018 and Dec 2024, across 29 billing codes. Its largest line is Q0084, Chemotherapy administration by infusion technique only, per visit — 27% of everything it billed.

33Billing provider infoCARIBBEAN CANCER CARE SERVICES, LLC
PONCE, PR 00717

33aNPI1679900567assigned 10/09/2013

33bProvider typeHematology & Oncology Physician

28Total paid$6.48M

24GClaims138,660

24DCodes billed29

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Hematology & Oncology Physician providers in Puerto Rico

Rank by total paid#1 of 59

Median peer was paid$110K

This provider vs. median59×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	10,894	$260K
2019	9,498	$256K
2020	9,523	$394K
2021	14,100	$536K
2022	19,755	$848K
2023	33,587	$1.89M
2024incomplete	41,303	$2.30M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
Q0084	Chemotherapy administration by infusion technique only, per visit	27%	20,717	11,201	$1.73M
96367		21%	18,442	9,707	$1.34M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	9.8%	12,950	9,975	$633K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	8.0%	11,998	7,430	$520K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	7.1%	5,132	2,558	$457K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	6.7%	12,607	7,418	$433K
96415		6.4%	4,861	2,405	$418K
J1453	Injection, fosaprepitant, 1 mg	4.5%	1,349	597	$294K
J1626	Injection, granisetron hydrochloride, 100 mcg	3.3%	14,158	7,896	$213K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	2.3%	1,457	1,150	$150K
Q0081	Infusion therapy, using other than chemotherapeutic drugs, per visit	1.6%	1,305	897	$103K
96417		1.1%	1,106	613	$72K

17 more codes

S0028	Injection, famotidine, 20 mg	<1%	7,379	$42K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	9,777	$17K
J3490	Unclassified drugs	<1%	558	$14K
96375	Therapeutic injection; each additional sequential IV push	<1%	717	$9K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	785	$9K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	9,417	$6K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	402	$6K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	314	$4K
96523		<1%	136	$3K
J2780	Injection, ranitidine hydrochloride, 25 mg	<1%	1,063	$2K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	1,586	$1K
99442		<1%	27	$906.13
96402		<1%	52	$848.88
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	19	$94.78
J7050	Infusion, normal saline solution, 250 cc	<1%	257	$34.84
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	17	$11.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	72	$9.75

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialJIMENEZ, ROLANDO (PRESIDENT)